FOLFIRINOX combined to targeted therapy according RAS status for colorectal cancer patients with liver metastases initially non-resectable: A phase II randomized Study—Prodige 14 – ACCORD 21 (METHEP-2), a unicancer GI trial

Marc Ychou; Michel Rivoire; Simon Thezenas; Rosine Guimbaud; Francois Ghiringhelli; Anne Mercier-Blas; Laurent Mineur; Eric Francois; Faiza Khemissa; Driffa Moussata; Yves Becouarn; Philippe Houyau; Thomas Aparicio; Rene Adam; Marie-Pierre Galais; Franck Audemar; Eric Assenat; Trevor Stanbury; Olivier Bouche

doi:10.1200/JCO.2016.34.15_suppl.3512

Retour

FOLFIRINOX combined to targeted therapy according RAS status for colorectal cancer patients with liver metastases initially non-resectable: A phase II randomized Study—Prodige 14 – ACCORD 21 (METHEP-2), a unicancer GI trial

Article de revue

Avec comité de lecture

FOLFIRINOX combined to targeted therapy according RAS status for colorectal cancer patients with liver metastases initially non-resectable: A phase II randomized Study—Prodige 14 – ACCORD 21 (METHEP-2), a unicancer GI trial

Marc Ychou, Michel Rivoire, Simon Thezenas, Rosine Guimbaud, Francois Ghiringhelli, Anne Mercier-Blas, Laurent Mineur, Eric Francois, Faiza Khemissa, Driffa Moussata, …

Journal of clinical oncology, Vol.34(15_suppl), pp.3512-3512

20/05/2016

DOI: https://doi.org/10.1200/JCO.2016.34.15_suppl.3512

Résumé

Abstract only

Indicateurs

1 Consultations de la notice

Détails

Titre: FOLFIRINOX combined to targeted therapy according RAS status for colorectal cancer patients with liver metastases initially non-resectable: A phase II randomized Study—Prodige 14 – ACCORD 21 (METHEP-2), a unicancer GI trial
Créateurs - sans rôle: Marc Ychou - Montpellier Cancer Institute, Montpellier, France
Michel Rivoire - Centre Léon Bérard
Simon Thezenas - Institut Régional du Cancer Montpellier, Montpellier, France
Rosine Guimbaud - University Hospital of Rangueil, Toulouse, France
Francois Ghiringhelli - Centre Georges François Leclerc
Anne Mercier-Blas - Centre Hospitalier Privé de Saint-Grégoire, Saint-Grégoire, France
Laurent Mineur - Institut Sainte Catherine
Eric Francois - Centre Antoine Lacassagne
Faiza Khemissa - CH Saint Jean, Perpignan, France
Driffa Moussata - CHU Tours, TOURS, France
Yves Becouarn - Institut Bergonié
Philippe Houyau - Clinique Claude Bernard, Albi, France
Thomas Aparicio - Assistance Publique – Hôpitaux de Paris
Rene Adam - Centre Hépato-Biliaire, AP-HP, Hôpital Paul Brousse, Villejuif, France
Marie-Pierre Galais - Centre François Baclesse, Caen, France
Franck Audemar - Centre hospitalier Côte Basque, Bayonne, France
Eric Assenat - Hôpital Saint Eloi
Trevor Stanbury - UNICANCER, Paris, France
Olivier Bouche - Hôpital Robert-Debré
Détails de publication: Journal of clinical oncology, Vol.34(15_suppl), pp.3512-3512
Identifiants: 99139779109311
Unité académique: Institut de Recherche en Cancérologie de Montpellier - IRCM; Institut de Génétique Moléculaire de Montpellier - IGMM
Langue: English
Type de ressource: Journal article